ICROM srl is an Italian CDMO dedicated to the development and the GMP manufacture of Active Ingredients and Intermediates for pharmaceutical use on a small, medium and large scale. ICROM holds segregated GMP units for the development and manufacture of high-potent APIs mainly for oncological application, supporting clinical phases (in USA, JP and EU) as well as development and commercial productions of non-potent APIs for Specialty Drugs. All Icrom’s facilities are regularly inspected and approved by the main Regulatory Agencies (EMA, US-FDA, Japanese PMDA) so to efficiently support projects targeting a global presence on the worldwide pharmaceutical markets. Thanks to its strong and experienced R&D team, which is operating in new and state-of-the-art laboratories and to its multi-scale and advanced workshops, ICROM can follow the drug development efforts of its clients from the preclinical stages through all the clinical phases and up to the drug’s commercial manufacturing by the design and the development of an efficient and scalable manufacturing process in compliance with the most recent regulatory requirements.